(VIANEWS) – Today, the Innrs artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of ConAgra Foods CAG, Citizens Financial Group CFG and others.
Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.
Innrs provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.
Innrs officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.
In the next session, Via News will report the finding on the algorithm precision.
| Financial Asset | Accuracy | Close Price | Prediction |
|---|---|---|---|
| ConAgra Foods (CAG) | 93.47% | $38.49 | ⇧ $38.75 |
| Citizens Financial Group (CFG) | 92.91% | $26.17 | ⇧ $26.62 |
| Coca-Cola (KO) | 92.9% | $64 | ⇧ $65.64 |
| Yum! (YUM) | 89.27% | $137.33 | ⇧ $140.34 |
| Tenet Healthcare (THC) | 88.95% | $69.92 | ⇧ $71.24 |
| Fifth Third Bancorp (FITBI) | 88.93% | $24.38 | ⇧ $24.62 |
| HCA Holdings (HCA) | 88.65% | $280.15 | ⇧ $281.18 |
| Incyte Corporation (INCY) | 88.59% | $68.69 | ⇧ $70.26 |
| Amicus Therapeutics (FOLD) | 88.54% | $12.03 | ⇧ $12.03 |
| Hormel Foods (HRL) | 88.32% | $40.61 | ⇧ $41.92 |
| General Mills (GIS) | 88.3% | $88.76 | ⇧ $90.97 |
| Unilever (UL) | 88.23% | $55.6 | ⇧ $56.87 |
| McCormick & Company (MKC) | 88.14% | $88.1 | ⇧ $90.39 |
| Laboratory Corporation of America Holdings (LH) | 88.13% | $226.03 | ⇧ $229.79 |
| Intuitive Surgical (ISRG) | 87.42% | $304.96 | ⇧ $312.52 |
| Electronic Arts (EA) | 87.38% | $125.04 | ⇧ $127.42 |
| Johnson & Johnson (JNJ) | 87.15% | $164.39 | ⇧ $169.28 |
| Kodak (KODK) | 84.85% | $3.3 | ⇩ $3 |
| Kimberly (KMB) | 84.29% | $146.71 | ⇧ $148.91 |
| Coca-Cola Consolidated (COKE) | 84.18% | $596.04 | ⇧ $599.19 |
| Smith & Nephew (SNN) | 84.03% | $32.12 | ⇧ $32.57 |
| Mastercard (MA) | 84.01% | $377.76 | ⇧ $383.9 |
| America Movil (AMX) | 84% | $21.6 | ⇧ $21.86 |
| Uber (UBER) | 83.99% | $37.87 | ⇩ $36.97 |
| Kellogg Company (K) | 83.98% | $71.62 | ⇧ $72.99 |
| Air Products and Chemicals (APD) | 83.93% | $294.22 | ⇧ $303.39 |
| Exelon (EXC) | 83.83% | $42.64 | ⇧ $43.65 |
| Biogen (BIIB) | 83.77% | $311.1 | ⇧ $315.72 |
1. ConAgra Foods (CAG)
Shares of ConAgra Foods rose 2.23% in from $37.65 to $38.49 at 19:21 EST on Wednesday, after five consecutive sessions in a row of gains. NYSE is dropping 0.53% to $15,233.85, after two successive sessions in a row of losses.
Conagra Brands, Inc., together with its subsidiaries, operates as a consumer packaged goods food company in North America. The company operates in four segments: Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice. The Grocery & Snacks segment primarily offers shelf stable food products through various retail channels in the United States. The Refrigerated & Frozen segment provides temperature-controlled food products through various retail channels in the United States. The International segment offers food products in various temperature states through retail and foodservice channels outside of the United States. The Foodservice segment offers branded and customized food products, including meals, entrees, sauces, and various custom-manufactured culinary products packaged for restaurants and other foodservice establishments in the United States. The company sells its products under the Birds Eye, Duncan Hines, Healthy Choice, Marie Callender's, Reddi-wip, Slim Jim, Angie's BOOMCHICKAPOP, Duke's, Earth Balance, Gardein, and Frontera brands. The company was formerly known as ConAgra Foods, Inc. and changed its name to Conagra Brands, Inc. in November 2016. Conagra Brands, Inc. was founded in 1919 and is headquartered in Chicago, Illinois.
Sales Growth
ConAgra Foods’s sales growth is 4.6% for the present quarter and 4.3% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 6.2% and positive 10.5% for the next.
More news about ConAgra Foods.
2. Citizens Financial Group (CFG)
Shares of Citizens Financial Group dropped by a staggering 11.39% in from $29.53 to $26.17 at 19:21 EST on Wednesday, after two consecutive sessions in a row of losses. NYSE is dropping 0.53% to $15,233.85, after two consecutive sessions in a row of losses.
Citizens Financial Group, Inc. operates as the bank holding company for Citizens Bank, National Association that provides retail and commercial banking products and services to individuals, small businesses, middle-market companies, corporations, and institutions in the United States. The company operates in two segments, Consumer Banking and Commercial Banking. The Consumer Banking segment offers deposit products, mortgage and home equity lending products, credit cards, business loans, wealth management, and investment services; and auto, education, and point-of-sale finance loans, as well as digital deposit products. This segment serves its customers through telephone service centers, as well as through its online and mobile platforms. The Commercial Banking segment provides various financial products and solutions, including lending and leasing, deposit and treasury management services, foreign exchange, and interest rate and commodity risk management solutions, as well as syndicated loans, corporate finance, mergers and acquisitions, and debt and equity capital markets services. This segment serves government banking, not-for-profit, healthcare, technology, professionals, oil and gas, asset finance, franchise finance, asset-based lending, commercial real estate, private equity, and sponsor finance industries. The company was formerly known as RBS Citizens Financial Group, Inc. and changed its name to Citizens Financial Group, Inc. in April 2014. Citizens Financial Group, Inc. was founded in 1828 and is headquartered in Providence, Rhode Island.
Volatility
Citizens Financial Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.11%, a negative 0.50%, and a positive 2.12%.
Citizens Financial Group’s highest amplitude of average volatility was 4.64% (last week), 2.04% (last month), and 2.12% (last quarter).
Yearly Top and Bottom Value
Citizens Financial Group’s stock is valued at $26.17 at 19:21 EST, under its 52-week low of $28.27.
Moving Average
Citizens Financial Group’s worth is way below its 50-day moving average of $36.33 and way under its 200-day moving average of $37.96.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.7%, now sitting on 7.55B for the twelve trailing months.
More news about Citizens Financial Group.
3. Coca-Cola (KO)
Shares of Coca-Cola jumped 2.98% in from $62.15 to $64.00 at 19:21 EST on Wednesday, following the last session’s downward trend. NYSE is sliding 0.53% to $15,233.85, after two successive sessions in a row of losses.
The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Coca-Cola’s stock is considered to be oversold (<=20).
Volatility
Coca-Cola’s last week, last month’s, and last quarter’s current intraday variation average was 0.20%, 0.12%, and 0.52%.
Coca-Cola’s highest amplitude of average volatility was 0.33% (last week), 0.33% (last month), and 0.52% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 2.9% and 2.9%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.7%, now sitting on 43.49B for the twelve trailing months.
More news about Coca-Cola.
4. Yum! (YUM)
Shares of Yum! jumped 4.5% in from $131.42 to $137.33 at 19:21 EST on Wednesday, after five consecutive sessions in a row of gains. NYSE is sliding 0.53% to $15,233.85, after two consecutive sessions in a row of losses.
Yum! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. The company operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. It operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to Yum! Brands, Inc. in May 2002. Yum! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.
More news about Yum!.
5. Tenet Healthcare (THC)
Shares of Tenet Healthcare rose by a staggering 19.66% in from $58.43 to $69.92 at 19:21 EST on Wednesday, after five sequential sessions in a row of losses. NYSE is falling 0.53% to $15,233.85, after two successive sessions in a row of losses.
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates through three segments: Hospital Operations, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Further, the company offers end-to-end and focused-point business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Yearly Top and Bottom Value
Tenet Healthcare’s stock is valued at $69.92 at 19:21 EST, under its 52-week high of $76.37 and way above its 52-week low of $36.69.
Volatility
Tenet Healthcare’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.14%, a positive 0.90%, and a positive 2.12%.
Tenet Healthcare’s highest amplitude of average volatility was 1.30% (last week), 1.43% (last month), and 2.12% (last quarter).
More news about Tenet Healthcare.
6. Fifth Third Bancorp (FITBI)
Shares of Fifth Third Bancorp rose 5.27% in from $23.16 to $24.38 at 19:21 EST on Wednesday, following the last session’s downward trend. NASDAQ is dropping 0.46% to $12,025.33, after two sequential sessions in a row of losses.
Fifth Third Bancorp operates as a diversified financial services company in the United States. It operates through three segments: Commercial Banking, Consumer and Small Business Banking, and Wealth and Asset Management. The company's Commercial Banking segment offers credit intermediation, cash management, and financial services; lending and depository products; and cash management, foreign exchange and international trade finance, derivatives and capital markets services, asset-based lending, real estate finance, public finance, commercial leasing, and syndicated finance for business, government, and professional customers. The company's Consumer and Small Banking segment provides a range of deposit and loan products to individuals and small businesses; home equity loans and lines of credit; credit cards; and cash management services. This segment also engages in the residential mortgage that include origination, retention and servicing of residential mortgage loans, sales and securitizations of loans, and hedging activities; indirect lending, including extending loans to consumers through automobile dealers, motorcycle dealers, powersport dealers, recreational vehicle dealers, and marine dealers; and home improvement and solar energy installation loans through contractors and installers. Fifth Third Bancorp's Wealth & Asset Management segment provides various wealth management services for individuals, companies, and not-for-profit organizations. It offers retail brokerage services to individual clients; and broker dealer services to the institutional marketplace. This segment also provides wealth planning, investment management, banking, insurance, and trust and estate services; and advisory services for institutional clients comprising middle market businesses, non-profits, states, and municipalities. Fifth Third Bancorp was founded in 1858 and is headquartered in Cincinnati, Ohio.
Yearly Top and Bottom Value
Fifth Third Bancorp’s stock is valued at $24.38 at 19:21 EST, below its 52-week high of $27.06 and way higher than its 52-week low of $21.08.
Moving Average
Fifth Third Bancorp’s worth is higher than its 50-day moving average of $24.21 and under its 200-day moving average of $25.18.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Fifth Third Bancorp’s stock is considered to be oversold (<=20).
Volatility
Fifth Third Bancorp’s last week, last month’s, and last quarter’s current intraday variation average was 0.28%, 0.23%, and 1.33%.
Fifth Third Bancorp’s highest amplitude of average volatility was 0.32% (last week), 0.74% (last month), and 1.33% (last quarter).
More news about Fifth Third Bancorp.
7. HCA Holdings (HCA)
Shares of HCA Holdings rose 5.46% in from $265.65 to $280.15 at 19:21 EST on Wednesday, after four sequential sessions in a row of losses. NYSE is dropping 0.53% to $15,233.85, after two successive sessions in a row of losses.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 0.7% and 3.8%, respectively.
Moving Average
HCA Holdings’s worth is above its 50-day moving average of $260.98 and way higher than its 200-day moving average of $232.29.
Sales Growth
HCA Holdings’s sales growth is 5.2% for the current quarter and 5.1% for the next.
More news about HCA Holdings.
8. Incyte Corporation (INCY)
Shares of Incyte Corporation fell 5.63% in from $72.79 to $68.69 at 19:21 EST on Wednesday, following the last session’s downward trend. NASDAQ is dropping 0.46% to $12,025.33, after two consecutive sessions in a row of losses.
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States, Europe, Japan, and internationally. The company offers JAKAFI (ruxolitinib), for the treatment of adults with intermediate or high-risk myelofibrosis; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include axatilimab, an anti-CSF-1R monoclonal antibody being developed as a therapy for patients with chronic GVHD as well as in additional immune-mediated diseases; and parsaclisib, a PI3Kd inhibitor which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. It also develops retifanlimab, is in Phase III clinical trials for squamous cell carcinoma of the anal canal and non-small cell lung cancer, and Fast Track designation for the treatment of metastatic MSI-H or DNA mismatch repair (dMMR) endometrial cancer; and INCB99280 and INCB99318 currently under Phase I for the treatment solid tumors. It has collaboration out- license agreements with Novartis, Lilly, Innovent, InnoCare, Maruho, and CMS Aesthetics Limited; and in- license agreements with Agenus, Merus, MacroGenics, Syros, MorphoSys, and Syndax. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.
Sales Growth
Incyte Corporation’s sales growth is 16.8% for the current quarter and 1.5% for the next.
Volatility
Incyte Corporation’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.31%, a negative 0.20%, and a positive 1.24%.
Incyte Corporation’s highest amplitude of average volatility was 2.53% (last week), 1.32% (last month), and 1.24% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 32.7% and a drop 11.9% for the next.
More news about Incyte Corporation.
9. Amicus Therapeutics (FOLD)
Shares of Amicus Therapeutics rose by a staggering 10.06% in from $10.93 to $12.03 at 19:21 EST on Wednesday, following the last session’s downward trend. NASDAQ is sliding 0.46% to $12,025.33, after two successive sessions in a row of losses.
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. The company also develops AT-GAA, a novel treatment paradigm for Pompe disease; and enzyme replacement therapies for Pompe diseases. It has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. The company was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.
Sales Growth
Amicus Therapeutics’s sales growth is 6.2% for the ongoing quarter and 11.9% for the next.
Moving Average
Amicus Therapeutics’s value is higher than its 50-day moving average of $12.01 and higher than its 200-day moving average of $11.54.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 50% and 42.9%, respectively.
Yearly Top and Bottom Value
Amicus Therapeutics’s stock is valued at $12.03 at 19:21 EST, way below its 52-week high of $13.84 and way above its 52-week low of $5.91.
More news about Amicus Therapeutics.
10. Hormel Foods (HRL)
Shares of Hormel Foods fell 0.81% in from $40.94 to $40.61 at 19:21 EST on Wednesday, after two sequential sessions in a row of losses. NYSE is dropping 0.53% to $15,233.85, after two consecutive sessions in a row of losses.
Hormel Foods Corporation develops, processes, and distributes various meat, nuts, and food products to retail, foodservice, deli, and commercial customers in the United States and internationally. The company operates through four segments: Grocery Products, Refrigerated Foods, Jennie-O Turkey Store, and International & Other. It provides various perishable products that include fresh meats, frozen items, refrigerated meal solutions, sausages, hams, guacamoles, and bacons; and shelf-stable products comprising canned luncheon meats, nut butters, snack nuts, chilies, shelf-stable microwaveable meals, hashes, stews, tortillas, salsas, tortilla chips, and others. The company also engages in the processing, marketing, and sale of branded and unbranded pork, beef, poultry, and turkey products, as well as offers nutritional food products and supplements, desserts and drink mixes, and industrial gelatin products. It sells its products primarily under the SKIPPY, SPAM, Hormel, Natural Choice, Applegate, Justin's, Jennie-O, Café H, Herdez, Black Label, Sadler's, Columbus, Gatherings, Herdez, Wholly, Columbus, Planters, NUT-rition, Planters Cheez Balls, Corn Nuts, etc. brand names through sales personnel, independent brokers, and distributors. The company was formerly known as Geo. A. Hormel & Company and changed its name to Hormel Foods Corporation in January 1995. Hormel Foods Corporation was founded in 1891 and is headquartered in Austin, Minnesota.
More news about Hormel Foods.
11. General Mills (GIS)
Shares of General Mills jumped 3.13% in from $86.07 to $88.76 at 19:21 EST on Wednesday, after two sequential sessions in a row of losses. NYSE is sliding 0.53% to $15,233.85, after two sequential sessions in a row of losses.
General Mills, Inc. manufactures and markets branded consumer foods worldwide. The company operates in five segments: North America Retail; Convenience Stores & Foodservice; Europe & Australia; Asia & Latin America; and Pet. It offers ready-to-eat cereals, refrigerated yogurt, soup, meal kits, refrigerated and frozen dough products, dessert and baking mixes, bakery flour, frozen pizza and pizza snacks, snack bars, fruit and salty snacks, ice cream, nutrition bars, wellness beverages, and savory and grain snacks, as well as various organic products, including frozen and shelf-stable vegetables. It also supplies branded and unbranded food products to the North American foodservice and commercial baking industries; and manufactures and markets pet food products, including dog and cat food. The company markets its products under the Annie's, Betty Crocker, Bisquick, Blue Buffalo, Blue Basics, Blue Freedom, Bugles, Cascadian Farm, Cheerios, Chex, Cinnamon Toast Crunch, Cocoa Puffs, Cookie Crisp, EPIC, Fiber One, Food Should Taste Good, Fruit by the Foot, Fruit Gushers, Fruit Roll-Ups, Gardetto's, Go-Gurt, Gold Medal, Golden Grahams, Häagen-Dazs, Helpers, Jus-Rol, Kitano, Kix, Lärabar, Latina, Liberté, Lucky Charms, Muir Glen, Nature Valley, Oatmeal Crisp, Old El Paso, Oui, Pillsbury, Progresso, Raisin Nut Bran, Total, Totino's, Trix, Wanchai Ferry, Wheaties, Wilderness, Yoki, and Yoplait trademarks. It sells its products directly, as well as through broker and distribution arrangements to grocery stores, mass merchandisers, membership stores, natural food chains, e-commerce retailers, commercial and noncommercial foodservice distributors and operators, restaurants, convenience stores, and pet specialty stores, as well as drug, dollar, and discount chains. The company operates 466 leased and 392 franchise ice cream parlors. General Mills, Inc. was founded in 1866 and is headquartered in Minneapolis, Minnesota.
Volatility
General Mills’s last week, last month’s, and last quarter’s current intraday variation average was 0.42%, 0.21%, and 0.79%.
General Mills’s highest amplitude of average volatility was 0.65% (last week), 0.51% (last month), and 0.79% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, General Mills’s stock is considered to be oversold (<=20).
Sales Growth
General Mills’s sales growth is 5.3% for the ongoing quarter and 5.4% for the next.
Moving Average
General Mills’s value is above its 50-day moving average of $80.78 and way higher than its 200-day moving average of $79.45.
More news about General Mills.
12. Unilever (UL)
Shares of Unilever rose 5.06% in from $52.92 to $55.60 at 19:21 EST on Wednesday, following the last session’s upward trend. NYSE is falling 0.53% to $15,233.85, after two sequential sessions in a row of losses.
Unilever PLC operates as a fast-moving consumer goods company. It operates through Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream segments. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products, which includes the vitamins, minerals, and supplements. Personal Care segment offers skin cleansing products comprising soap and shower, deodorant and oral care products, such as toothpaste, toothbrush, and mouthwash products. Home Care segment engages in the sale of fabric care including washing powders and liquids, and rinse conditioners; and home and hygiene, fabric enhancers, water and air wellness products. Nutrition segment provides the sale of scratch cooking aids, which includes soups, bouillons, and seasonings; dressings products, such as mayonnaise and ketchup; and beverages and functional nutrition products including Horlicks and Boost, as well as tea products. Ice Cream segment offers ice cream products including in-home and out-of-home ice creams. It offers its products under the AXE, Bango, Ben & Jerry's, Cif, Comfort, Domestos, Dove, Equilibra, Hellmann's, Knorr, LUX, Lifebuoy, Liquid I.V., Love Beauty & Planet, Magnum, OLLY, OMO, Onnit, Rexona, Seventh Generation, SmartPants, Sunsilk, The Vegetarian Butcher, Vaseline, and Wall's brands. The company was founded in 1860 and is headquartered in London, the United Kingdom.
More news about Unilever.
13. McCormick & Company (MKC)
Shares of McCormick & Company rose 3.32% in from $85.27 to $88.10 at 19:21 EST on Wednesday, after two sequential sessions in a row of losses. NYSE is dropping 0.53% to $15,233.85, after two successive sessions in a row of losses.
McCormick & Company, Incorporated manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavorful products to the food industry. It operates in two segments, Consumer and Flavor Solutions. The Consumer segment offers spices, herbs, and seasonings, as well as condiments and sauces, and desserts. This segment markets its products under the McCormick, French's, Frank's RedHot, Lawry's, Cholula Hot Sauce, Gourmet Garden, Club House, and OLD BAY brands in the Americas; Ducros, Schwartz, Kamis, and LA Drogheria, and Vahiné brands in Europe, the Middle East, and Africa; McCormick and DaQiao brands in China; and McCormick, Aeroplane, and Gourmet Garden brands in Australia, as well as markets regional and ethnic brands, such as Zatarain's, Stubb's, Thai Kitchen, and Simply Asia. It also supplies its products under the private labels. This segment serves retailers comprising grocery, mass merchandise, warehouse clubs, discount and drug stores, and e-commerce retailers directly and indirectly through distributors and wholesale foodservice suppliers. The Flavor Solutions segment offers seasoning blends, spices and herbs, condiments, coating systems, and compound flavors to multinational food manufacturers and foodservice customers. It serves foodservice customers directly and indirectly through distributors. McCormick & Company, Incorporated was founded in 1889 and is headquartered in Hunt Valley, Maryland.
Yearly Top and Bottom Value
McCormick & Company’s stock is valued at $88.10 at 19:21 EST, way under its 52-week high of $105.19 and way higher than its 52-week low of $70.60.
Moving Average
McCormick & Company’s worth is way higher than its 50-day moving average of $76.45 and above its 200-day moving average of $80.56.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.8%, now sitting on 6.39B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, McCormick & Company’s stock is considered to be oversold (<=20).
More news about McCormick & Company.
14. Laboratory Corporation of America Holdings (LH)
Shares of Laboratory Corporation of America Holdings dropped 2.15% in from $231 to $226.03 at 19:21 EST on Wednesday, after two sequential sessions in a row of losses. NYSE is sliding 0.53% to $15,233.85, after two successive sessions in a row of losses.
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Laboratory Corporation of America Holdings’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
Laboratory Corporation of America Holdings’s stock is valued at $226.03 at 19:21 EST, way below its 52-week high of $280.72 and way above its 52-week low of $200.32.
More news about Laboratory Corporation of America Holdings.
15. Intuitive Surgical (ISRG)
Shares of Intuitive Surgical rose by a staggering 19.86% in from $254.43 to $304.96 at 19:21 EST on Wednesday, following the last session’s downward trend. NASDAQ is sliding 0.46% to $12,025.33, after two consecutive sessions in a row of losses.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Yearly Top and Bottom Value
Intuitive Surgical’s stock is valued at $304.96 at 19:21 EST, higher than its 52-week high of $304.84.
Volatility
Intuitive Surgical’s last week, last month’s, and last quarter’s current intraday variation average was 0.53%, 0.94%, and 1.38%.
Intuitive Surgical’s highest amplitude of average volatility was 0.83% (last week), 1.32% (last month), and 1.38% (last quarter).
More news about Intuitive Surgical.
16. Electronic Arts (EA)
Shares of Electronic Arts slid 0.1% in from $125.17 to $125.04 at 19:21 EST on Wednesday, following the last session’s downward trend. NASDAQ is sliding 0.46% to $12,025.33, after two sequential sessions in a row of losses.
Electronic Arts Inc. develops, markets, publishes, and distributes games, content, and services for game consoles, PCs, mobile phones, and tablets worldwide. It develops and publishes games and services across various genres, such as sports, racing, first-person shooter, action, role-playing, and simulation primarily under the Battlefield, The Sims, Apex Legends, Need for Speed, and license games from others, including FIFA, Madden NFL, UFC, and Star Wars brands. The company licenses its games to third parties to distribute and host its games. It markets and sells its games and services through digital distribution and retail channels, as well as directly to mass market retailers, specialty stores, and distribution arrangements. Electronic Arts Inc. was incorporated in 1982 and is headquartered in Redwood City, California.
Moving Average
Electronic Arts’s value is above its 50-day moving average of $118.55 and above its 200-day moving average of $123.55.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 9.6% and positive 80.9% for the next.
Yearly Top and Bottom Value
Electronic Arts’s stock is valued at $125.04 at 19:21 EST, way under its 52-week high of $142.79 and way above its 52-week low of $108.53.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.1%, now sitting on 7.38B for the twelve trailing months.
More news about Electronic Arts.
17. Johnson & Johnson (JNJ)
Shares of Johnson & Johnson jumped 3.69% in from $158.54 to $164.39 at 19:21 EST on Wednesday, following the last session’s upward trend. NYSE is sliding 0.53% to $15,233.85, after two consecutive sessions in a row of losses.
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Volatility
Johnson & Johnson’s last week, last month’s, and last quarter’s current intraday variation average was 0.18%, 0.25%, and 0.76%.
Johnson & Johnson’s highest amplitude of average volatility was 0.25% (last week), 0.80% (last month), and 0.76% (last quarter).
More news about Johnson & Johnson.
18. Kodak (KODK)
Shares of Kodak fell by a staggering 23.33% in from $4.3 to $3.30 at 19:21 EST on Wednesday, following the last session’s upward trend. NYSE is dropping 0.53% to $15,233.85, after two successive sessions in a row of losses.
Eastman Kodak Company provides hardware, software, consumables, and services to customers in the commercial print, packaging, publishing, manufacturing, and entertainment markets worldwide. The company operates through four segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment offers digital offset plate and computer-to-plate imaging solutions to commercial industries, including commercial print, direct mail, book publishing, newspapers and magazines, and packaging. The Digital Printing segment provides electrophotographic printing solutions, such as The ASCEND and NEXFINITY printers; prosper products, including the PROSPER 6000 Press, PROSPER Writing Systems, PROSPER press systems, and PROSPER components; versamark products; and PRINERGY workflow production software. The Advanced Materials and Chemicals segment engages in industrial film and chemicals, motion picture, and advanced materials and functional printing businesses. This segment also comprises the Kodak Research Laboratories, which conducts research, develops new product or new business opportunities, and files patent applications for its inventions and innovations, as well as manages licensing of its intellectual property to third parties. The Brand segment engages in the licensing of Kodak brand to third parties. The company engages in the operation of Eastman Business Park, a technology center and industrial complex. It sells its products and services through direct sales, third party resellers, dealers, channel partners, and distributors. Eastman Kodak Company was founded in 1880 and is headquartered in Rochester, New York.
Moving Average
Kodak’s value is under its 50-day moving average of $3.66 and way under its 200-day moving average of $4.40.
Yearly Top and Bottom Value
Kodak’s stock is valued at $3.30 at 19:21 EST, way below its 52-week high of $7.24 and way higher than its 52-week low of $2.78.
Volatility
Kodak’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.67%, a negative 1.48%, and a positive 2.45%.
Kodak’s highest amplitude of average volatility was 1.08% (last week), 1.93% (last month), and 2.45% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.7%, now sitting on 1.2B for the twelve trailing months.
More news about Kodak.
19. Kimberly (KMB)
Shares of Kimberly rose 9.32% in from $134.2 to $146.71 at 19:21 EST on Wednesday, after five consecutive sessions in a row of gains. NYSE is dropping 0.53% to $15,233.85, after two consecutive sessions in a row of losses.
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names. Its Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The company's K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. In addition, it sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through e-commerce. The company was founded in 1872 and is headquartered in Dallas, Texas.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 7.5% and 9.3%, respectively.
More news about Kimberly.
20. Coca-Cola Consolidated (COKE)
Shares of Coca-Cola Consolidated rose by a staggering 14.6% in from $520.1 to $596.04 at 19:21 EST on Wednesday, following the last session’s downward trend. NASDAQ is sliding 0.46% to $12,025.33, after two consecutive sessions in a row of losses.
Coca-Cola Consolidated, Inc., together with its subsidiaries, manufactures, markets, and distributes nonalcoholic beverages primarily products of The Coca-Cola Company in the United States. The company offers sparkling beverages, such as sparling beverages; and still beverages, including energy products, as well as noncarbonated beverages comprising bottled water, ready to drink coffee and tea, enhanced water, juices, and sports drinks. It also sells its products to other Coca-Cola bottlers; and post-mix products that are dispensed through equipment, which mixes the fountain syrup with carbonated or still water enabling fountain retailers to sell finished products to consumers in cups or glasses. In addition, the company distributes products for various other beverage brands that include Dr Pepper and Monster Energy. It sells and distributes its products directly to grocery stores, mass merchandise stores, club stores, convenience stores, and drug stores; and restaurants, schools, amusement parks, and recreational facilities, as well as through vending machine outlets. The company was formerly known as Coca-Cola Bottling Co. Consolidated and changed its name to Coca-Cola Consolidated, Inc. in January 2019. Coca-Cola Consolidated, Inc. was incorporated in 1980 and is headquartered in Charlotte, North Carolina.
More news about Coca-Cola Consolidated.
21. Smith & Nephew (SNN)
Shares of Smith & Nephew jumped by a staggering 14.02% in from $28.17 to $32.12 at 19:21 EST on Wednesday, after four successive sessions in a row of losses. NYSE is falling 0.53% to $15,233.85, after two sequential sessions in a row of losses.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Moving Average
Smith & Nephew’s worth is way higher than its 50-day moving average of $28.58 and way higher than its 200-day moving average of $26.50.
Volatility
Smith & Nephew’s last week, last month’s, and last quarter’s current intraday variation average was 0.62%, 0.78%, and 1.08%.
Smith & Nephew’s highest amplitude of average volatility was 0.68% (last week), 1.05% (last month), and 1.08% (last quarter).
More news about Smith & Nephew.
22. Mastercard (MA)
Shares of Mastercard rose 3.73% in from $364.18 to $377.76 at 19:21 EST on Wednesday, after five successive sessions in a row of losses. NYSE is dropping 0.53% to $15,233.85, after two consecutive sessions in a row of losses.
Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. It facilitates the processing of payment transactions, including authorization, clearing, and settlement, as well as delivers other payment-related products and services. The company offers integrated products and value-added services for account holders, merchants, financial institutions, businesses, governments, and other organizations, such as programs that enable issuers to provide consumers with credits to defer payments; payment products and solutions that allow its customers to access funds in deposit and other accounts; prepaid programs services; and commercial credit, debit, and prepaid payment products and solutions. It also provides value-added products and services comprising cyber and intelligence solutions for parties to transact, as well as proprietary insights, drawing on principled use of consumer, and merchant data services. In addition, the company offers analytics, test and learn, consulting, managed services, loyalty, processing, and payment gateway solutions for e-commerce merchants. Further, it provides open banking and digital identity platforms services. The company offers payment solutions and services under the MasterCard, Maestro, and Cirrus. Mastercard Incorporated was founded in 1966 and is headquartered in Purchase, New York.
Yearly Top and Bottom Value
Mastercard’s stock is valued at $377.76 at 19:21 EST, under its 52-week high of $390.00 and way above its 52-week low of $276.87.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Mastercard’s stock is considered to be oversold (<=20).
More news about Mastercard.
23. America Movil (AMX)
Shares of America Movil rose 1.41% in from $21.3 to $21.60 at 19:21 EST on Wednesday, following the last session’s upward trend. NYSE is dropping 0.53% to $15,233.85, after two successive sessions in a row of losses.
América Móvil, S.A.B. de C.V. provides telecommunications services in Latin America and internationally. The company offers wireless and fixed voice services, including local, domestic, and international long-distance services; and network interconnection services. It also provides data services, such as data centers, data administration, and hosting services to residential and corporate clients; value-added services, including Internet access, messaging, and other wireless entertainment and corporate services; data transmission, email services, instant messaging, content streaming, and interactive applications; and wireless security services, mobile payment solutions, machine-to-machine services, mobile banking, virtual private network services, and video calls and personal communications services. In addition, the company offers residential broadband services; IT solutions for small businesses and large corporations; and cable and satellite pay television subscriptions. Further, it sells equipment, accessories, and computers; and offers telephone directories, wireless security, call center, advertising, media, and software development services. Additionally, the company provides video, audio, and other media content through the Internet directly from the content provider to the end user. It sells its products and services under the Telcel, Telmex Infinitum, and A1 brands through a network of retailers and service centers to retail customers; and through sales force to corporate customers. América Móvil, S.A.B. de C.V. was incorporated in 2000 and is based in Mexico City, Mexico.
More news about America Movil.
24. Uber (UBER)
Shares of Uber jumped by a staggering 20.57% in from $31.41 to $37.87 at 19:21 EST on Wednesday, after five successive sessions in a row of gains. NYSE is sliding 0.53% to $15,233.85, after two sequential sessions in a row of losses.
Uber Technologies, Inc. develops and operates proprietary technology applications in the United States, Canada, Latin America, Europe, the Middle East, Africa, and Asia excluding China and Southeast Asia. It operates through three segments: Mobility, Delivery, and Freight. The Mobility segment connects consumers with a range of transportation modalities, such as ridesharing, carsharing, micromobility, rentals, public transit, taxis, and other modalities; and offers riders in a variety of vehicle types, as well as financial partnerships products and advertising services. The Delivery segment allows to search for and discover restaurants to grocery, alcohol, convenience, and other retails; order a meal or other items; and Uber direct, a white-label Delivery-as-a-Service for retailers and restaurants, as well as advertising. The Freight segment manages transportation and logistics network, which connects shippers and carriers in digital marketplace including carriers upfronts, pricing, and shipment booking; and provides on-demand platform to automate logistics end-to-end transactions for small-and medium-sized business to global enterprises. Uber Technologies, Inc. was formerly known as Ubercab, Inc. and changed its name to Uber Technologies, Inc. in February 2011. The company was founded in 2009 and is headquartered in San Francisco, California.
Revenue Growth
Year-on-year quarterly revenue growth grew by 49%, now sitting on 31.88B for the twelve trailing months.
Yearly Top and Bottom Value
Uber’s stock is valued at $37.87 at 19:21 EST, above its 52-week high of $37.58.
Moving Average
Uber’s value is way higher than its 50-day moving average of $32.08 and way higher than its 200-day moving average of $29.37.
Sales Growth
Uber’s sales growth is 27.3% for the current quarter and 12.9% for the next.
Previous days news about Uber
- Here's what key metrics tell us about Uber (Uber) Q1 earnings. According to Zacks on Tuesday, 2 May, "For the quarter ended March 2023, Uber Technologies (UBER Quick QuoteUBER – Free Report) reported revenue of $8.82 billion, up 28.7% over the same period last year. ", "Here is how Uber performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
- According to Zacks on Tuesday, 2 May, "Revenues of $8.82 billion outperformed the Zacks consensus by +1.44%, and well ahead of the $6.85 billion in Q1 of 2022, when the company was much more reliant on Uber Eats food delivery service. "
More news about Uber.
25. Kellogg Company (K)
Shares of Kellogg Company jumped 6.43% in from $67.29 to $71.62 at 19:21 EST on Wednesday, after five successive sessions in a row of gains. NYSE is dropping 0.53% to $15,233.85, after two sequential sessions in a row of losses.
Kellogg Company, together with its subsidiaries, manufactures and markets snacks and convenience foods. The company operates through four segments: North America, Europe, Latin America, and Asia Middle East Africa. Its principal products include crackers, crisps, savory snacks, toaster pastries, cereal bars, granola bars and bites, ready-to-eat cereals, frozen waffles, veggie foods, and noodles. The company offers its products under the Kellogg's, Cheez-It, Pringles, Austin, Parati, RXBAR, Kashi, Bear Naked, Eggo, Morningstar Farms, Choco Krispies, Crunchy Nut, Nutri-Grain, Special K, Squares, Zucaritas, Sucrilhos, Pop-Tarts, K-Time, Sunibrite, Split Stix, Be Natural, LCMs, Coco Pops, Frosties, Krave, Rice Krispies Treats, Kashi Go, Crunchy Nut, Rice Krispies Squares, Incogmeato, Veggitizers, and Gardenburger brand names. It sells its products to retailers through direct sales forces, as well as brokers and distributors. Kellogg Company was founded in 1906 and is headquartered in Battle Creek, Michigan.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Kellogg Company’s stock is considered to be oversold (<=20).
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 10% and a negative 6.8%, respectively.
Moving Average
Kellogg Company’s value is above its 50-day moving average of $66.56 and above its 200-day moving average of $70.81.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.1%, now sitting on 15.32B for the twelve trailing months.
More news about Kellogg Company.
26. Air Products and Chemicals (APD)
Shares of Air Products and Chemicals rose 3.27% in from $284.9 to $294.22 at 19:21 EST on Wednesday, following the last session’s downward trend. NYSE is dropping 0.53% to $15,233.85, after two successive sessions in a row of losses.
Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and related services in the Americas, Asia, Europe, the Middle East, India, and internationally. The company produces atmospheric gases, including oxygen, nitrogen, and argon; process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, and syngas; specialty gases; and equipment for the production or processing of gases comprising air separation units and non-cryogenic generators for customers in various industries, including refining, chemical, manufacturing, electronics, magnetic resonance imaging, energy production, medical, food, and metals. It also designs and manufactures equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction, and liquid helium and liquid hydrogen transport and storage. The company was founded in 1940 and is headquartered in Allentown, Pennsylvania.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 11.3% and 11.1%, respectively.
More news about Air Products and Chemicals.
27. Exelon (EXC)
Shares of Exelon rose 1.94% in from $41.83 to $42.64 at 19:21 EST on Wednesday, following the last session’s downward trend. NASDAQ is sliding 0.46% to $12,025.33, after two successive sessions in a row of losses.
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers. It also offers support services, including legal, human resources, information technology, supply management, financial, engineering, customer operations, distribution and transmission planning, asset management, system operations, and power procurement services. It serves distribution utilities, municipalities, cooperatives, and financial institutions, as well as commercial, industrial, governmental, and residential customers. Exelon Corporation was incorporated in 1999 and is headquartered in Chicago, Illinois.
Moving Average
Exelon’s worth is above its 50-day moving average of $41.82 and higher than its 200-day moving average of $41.81.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Exelon’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth declined by 51.5%, now sitting on 19.08B for the twelve trailing months.
More news about Exelon.
28. Biogen (BIIB)
Shares of Biogen rose by a staggering 13.12% in from $275.02 to $311.10 at 19:21 EST on Wednesday, following the last session’s downward trend. NASDAQ is sliding 0.46% to $12,025.33, after two sequential sessions in a row of losses.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; ADUHELM to treat Alzheimer's disease; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; and BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS. It also provides RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing various products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, immunology related diseases, neurovascular disorders, genetic neurodevelopmental disorders, and biosimilars, which are under various stages of development. Biogen Inc. has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Sales Growth
Biogen’s sales growth is negative 8.1% for the present quarter and negative 5.6% for the next.
Volatility
Biogen’s last week, last month’s, and last quarter’s current intraday variation average was 1.81%, 0.55%, and 1.23%.
Biogen’s highest amplitude of average volatility was 2.10% (last week), 1.41% (last month), and 1.23% (last quarter).
More news about Biogen.
